000513 · Livzon Pharmaceutical Group, Inc. Class A
29.96
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan24.80B
PE
15.20
EV/EBITDA
8
DIV Yield
4.4%
Payout Ratio
67%
MQV Rating
3Neutral
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO All
- HALO Price Momentum
- HALO Yield
- Quality Yield
Key Fundamentals
EPS 3 yr Growth
10.90%
EBITDA Margin
26.70%
Operating Cashflow
¥3,179m
Free Cash Flow Return
21.20%
ROIC
13.50%
Interest Coverage
51.50
Quick Ratio
2.00
Performance
52 weeks range
Low 27.67 - 43.74
Trade Value (12mth)
US$8,912,654.00
1 week
-2.45%
1 month
4.28%
YTD
-12.6%
1 year
-16.88%
All time high
62.20
Additional Data
Shares Outstanding (Fully Diluted)
888m
HALO Sector
Healthcare
Next Company Report Date
31-Mar-27
Next Ex Dividend Date
16-Jun-26
Next Dividend Pay Date
16-Jun-26
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Neutral
Garp
Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Strong
Growth
Earnings
Very Weak
Dividends
Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Very Weak
Valuation
News & Announcements
| Date | Event |
21 August 25Flash | |
24 April 25Flash | |
27 March 25Flash | |
24 October 24Flash | |
25 September 24Flash |